- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Synthetic double-stranded RNA oligonucleotide specific to hy
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Synthetic double-stranded RNA oligonucleotide specific to hydroxyacid oxidase 1 gene
| EU orphan designation number: | EU/3/15/1528
|
| Active ingredient: | Synthetic double-stranded RNA oligonucleotide specific to hydroxyacid oxidase 1 gene |
| Indication: | Treatment of primary hyperoxaluria type 1 |
| Sponsor: | Dicerna EU Limited
209 Tower Bridge Business Centre, 46-48 East Smithfield, London E1W 2AW, United Kingdom |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 30/07/2015 | Orphan designation | EMA/OD/052/15 | (2015)5437 of 28/07/2015 |
CONTACT
EU links
Directorate General Health & Consumers